Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Liabilities and Shareholders Equity: 2019-2025

Historic Liabilities and Shareholders Equity for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $779.8 million.

  • CureVac N.V's Liabilities and Shareholders Equity rose 30.04% to $779.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 billion, marking a year-over-year increase of 7.75%. This contributed to the annual value of $857.9 million for FY2024, which is 1.15% up from last year.
  • According to the latest figures from Q2 2025, CureVac N.V's Liabilities and Shareholders Equity is $779.8 million, which was down 0.13% from $780.8 million recorded in Q1 2025.
  • Over the past 5 years, CureVac N.V's Liabilities and Shareholders Equity peaked at $2.2 billion during Q2 2021, and registered a low of $599.6 million during Q2 2024.
  • Over the past 3 years, CureVac N.V's median Liabilities and Shareholders Equity value was $853.0 million (recorded in 2023), while the average stood at $849.6 million.
  • As far as peak fluctuations go, CureVac N.V's Liabilities and Shareholders Equity slumped by 54.45% in 2022, and later spiked by 30.04% in 2025.
  • CureVac N.V's Liabilities and Shareholders Equity (Quarterly) stood at $1.3 billion in 2021, then crashed by 33.74% to $877.9 million in 2022, then fell by 3.39% to $848.1 million in 2023, then grew by 1.15% to $857.9 million in 2024, then soared by 30.04% to $779.8 million in 2025.
  • Its last three reported values are $779.8 million in Q2 2025, $780.8 million for Q1 2025, and $857.9 million during Q4 2024.